OhioHealth Riverside Methodist Hospital

Columbus, Ohio 43214

9 studies enrolling now · 30 studies all time

What they study most

Acute Pulmonary Embolism, Aortic Aneurysm, Thoracic, Aortic Stenosis, Aortic Valve Stenosis, Arrythmia, Bicuspid Aortic Valve, CIED Related Infection, COVID-19 Disease, Carcinoma, Non-Small-Cell Lung, Cerebral Hemorrhage, Clostridium Difficile Infection, Coronary Arterial Disease (CAD)

Studies at this site

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. — Recruiting now
• Letrozole in Uterine Leiomyosarcoma — Recruiting now
• AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions — Recruiting now
• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis — Recruiting now
• Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma — Recruiting now
• REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE — Recruiting now
• Prevail Global Study — Recruiting now
• TTVR Early Feasibility Study — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling
• Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care — Completed
• Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients — Running, not enrolling
• Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study — Running, not enrolling
• Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant — Running, not enrolling
• VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial — Stopped early
• The PEERLESS Study — Completed
• Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults — Stopped early
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• Valiant Evo US Clinical Trial — Completed
• Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study — Stopped early
• ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH) — Completed
• The Medtronic TAVR 2.0 US Clinical Study — Completed
• Clostridium Difficile Vaccine Efficacy Trial — Completed
• Unpinning Termination Therapy for VT (US) — Stopped early
• FlowTriever Pulmonary Embolectomy Clinical Study — Completed
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry — Completed
• Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs — Withdrawn before enrolling
• Liposomal Bupivacaine Versus Standard Analgesia in Total Joint Arthroplasty (TJA) — Completed